Correlation Between Equillium and CG Oncology,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Equillium and CG Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and CG Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and CG Oncology, Common, you can compare the effects of market volatilities on Equillium and CG Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of CG Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and CG Oncology,.

Diversification Opportunities for Equillium and CG Oncology,

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between Equillium and CGON is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and CG Oncology, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CG Oncology, Common and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with CG Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CG Oncology, Common has no effect on the direction of Equillium i.e., Equillium and CG Oncology, go up and down completely randomly.

Pair Corralation between Equillium and CG Oncology,

Allowing for the 90-day total investment horizon Equillium is expected to generate 2.04 times more return on investment than CG Oncology,. However, Equillium is 2.04 times more volatile than CG Oncology, Common. It trades about 0.04 of its potential returns per unit of risk. CG Oncology, Common is currently generating about 0.0 per unit of risk. If you would invest  68.00  in Equillium on September 12, 2024 and sell it today you would earn a total of  2.00  from holding Equillium or generate 2.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy89.92%
ValuesDaily Returns

Equillium  vs.  CG Oncology, Common

 Performance 
       Timeline  
Equillium 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Equillium is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
CG Oncology, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CG Oncology, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, CG Oncology, is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Equillium and CG Oncology, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Equillium and CG Oncology,

The main advantage of trading using opposite Equillium and CG Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, CG Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CG Oncology, will offset losses from the drop in CG Oncology,'s long position.
The idea behind Equillium and CG Oncology, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios